The target hemoglobin A1c of less than 7% should remain the general goal for nonpregnant adults with diabetes, despite recent results from three large randomized trials showing that intensive glucose lowering did not reduce the risks of cardiovascular disease in people with longstanding type 2 diabetes. But glycemic targets that are either more or less stringent than that standard may be prudent for certain individuals with diabetes, according to a position statement issued jointly last month by the American College of Cardiology, American Diabetes Association, and American Heart Association and published online in the journals of each organization: the Journal...
